Abstract:Lianbo Hu, 1 Bingrong Zheng, 2 Yang Yang, 2 Chunmei Chen, 2 Meiwei Hu 2 1 Physical Examination Center, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, People's Republic of China; 2 Department of Hematology, the Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China Correspondence: Meiwei Hu, Department of Hematology, the Second Affiliated Hospital of Zhejiang Chinese Medical University, No. 318 Chaowang Road, Hangzhou, Zhejiang, 310014, People's Republic of China, Email Introduction: CircRNA is closely correlated with a wide variety of processes of acute myeloid leukemia (AML), whereas the novel circRNAs, their molecular mechanism and the specific function they played in AML should be explored in depth. Methods: The microarray chip data of AML patients and normal samples in the Gene Expression Omnibus (GEO) database were selected to differentially expressed (DE) circRNA, miRNA, and mRNA genes. The miRNA gene was the intersection of the circRNA target gene predicted using CSCD and the miRNA gene screened from AML patients, while the mRNA gene was the intersection of the target gene mRNA of miRNA predicted using miRanda and miRTarBase software and the mRNA gene screened from AML patients. The hub mRNAs related to survival were further screened through Cox proportional hazard regression. CircRNA/miRNA/mRNA interaction network was constructed by using Cytoscape software.10 circRNAs and 6 miRNAs in bone marrow mononuclear cells (BMMNCs) of AML patients (n=43) and healthy controls (n=35) were determined by RT-qPCR. Correlations between them were analyzed by Pearson correlation coefficient. Results: 10 circRNAs, 6 miRNAs, and 33 mRNAs were identified. Subsequently, the network of circRNAs, miRNAs, and hub genes was built using Cystoscope. Four key circRNAs, seven hub genes and their regulatory pathways were identified. The result of RT-qPCRs showed that hsa_circ_0009581 and hsa_circ_0005273 were significantly upregulated in AML patients while hsa_circ_0000497 and hsa_circ_0001947 were significantly downregulated. Hsa-miR-150-5p was significantly downregulated; hsa-miR-454-3p was upregulated in AML patients. Hsa_circ_0009581 and hsa-miR-150-5p; hsa_ circ_0001947 and hsa-miR-454-3p were inversely correlated using Pearson's correlation coefficient. Conclusion: This study suggests that differentially expressed circRNAs take on a critical significance to AML development and may be the effective therapeutic targets. We suppose that hsa_circ_0009581 promotes leukemia development through hsa-miR-150-5p and hsa_circ_0001947 through hsa-miR-454-3p. hsa_circ_0001947 and hsa_circ_0009581 may provide new directions in the pathogenesis of AML. Keywords: acute myeloid leukemia, circRNA, pathogenesis, bioinformation analysis Acute myeloid leukemia (AML) is a group of highly aggressive hematological malignancies with abnormal proliferation and differentiation of hematopoietic stem cells. 1 Abnormal blood cells proliferate in a considerable number and inhibit normal hematopoiesis, with the clinical manifestations of anemia, bleeding, hepatosplenomegaly and other organ infiltration. It is one of the most common hematologic malignancies, and the mortality rate is the highest compared with other types of leukemia. 2 The treatment is based on conventional chemotherapy and hematopoietic stem cell transplantation, and molecular targeted therapy and cellular immunotherapy are promising for treating AML patients. However, they are still at risk for drug resistance and disease recurrence, thus resulting in shorter survival and poorer quality of life. 3 Studying the molecular mechanism of AML development takes on a great significance in finding novel therapeutic targets and facilitating AML prognosis. Circular RNAs (circRNAs) are a special type of closed-loop non-coding RNA molecule without 5'-caps or 3' -polyadenylate tails. Existing research has suggested that circRNAs exhibit complex biological functions in the body. 4 An increasing number of studies have suggested that circRNAs play a vital role in the development of tumors. 5 Existing research has also suggested that circRNA is correlated with the emergence of drug-resistance in osteosarcoma, 6 breast cancer, 7 as well as chronic myeloid leukemia. 8 CircRNA is stably expressed and is present at high level in body fluids, making it an ideal candidate for noninvasive liquid biopsy biomarkers in tumors. 9 Existing research has suggested that circRNAs are capable of playing a role in the post-transcriptional regulation of AML by bind -Abstract Truncated-

Roles of the hsa_circ_0013880/USP32/Rap1b axis in the proliferation and apoptosis of acute myeloid leukemia cells

LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A

Circ_0009910 sponges miR‐491‐5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway

circSLC25A13 acts as a ceRNA to regulate AML progression via miR‐616‐3p/ADCY2 axis

Circ_0009910 shuttled by exosomes regulates proliferation, cell cycle and apoptosis of acute myeloid leukemia cells by regulating miR-5195-3p/GRB10 axis

CircFN1 promotes acute myeloid leukemia cell proliferation and invasion but refrains apoptosis via miR-1294/ARHGEF10L axis

Circ_0001602 aggravates the progression of acute myeloid leukemia by regulating the miR-192-5p/ZBTB20 axis

Circ_0035381 Regulates Acute Myeloid Leukemia Development by Modulating YWHAZ Expression Via Adsorbing Mir-582-3p

EIF4A3-induced Circ_0001187 facilitates AML suppression through promoting ubiquitin-proteasomal degradation of METTL3 and decreasing m6A modification level mediated by miR-499a-5p/RNF113A pathway

Identification of Potential Novel Prognosis-Related Genes Through Transcriptome Sequencing, Bioinformatics Analysis, and Clinical Validation in Acute Myeloid Leukemia

CircPLXNB2 regulates acute myeloid leukemia progression through miR-654-3p/CCND1 axis

MiRNA-142-3P and FUS can be Sponged by Long Noncoding RNA DUBR to Promote Cell Proliferation in Acute Myeloid Leukemia

Regulatory function and mechanism research for m6A modification WTAP via SUCLG2-AS1- miR-17-5p-JAK1 axis in AML

Dysregulation of miR-138-5p/RPS6KA1-AP2M1 Is Associated With Poor Prognosis in AML

Targeting UHRF1-SAP30-MXD4 axis for leukemia initiating cell eradication in myeloid leukemia

Crosstalk between circBMI1 and miR-338-5p/ID4 inhibits AML progression

CircZBTB46 predicts poor prognosis and promotes disease progression of myelodysplastic syndromes and acute myeloid leukemia

Construction of circRNA–miRNA–mRNA Network Reveal Functional circRNAs and Key Genes in Acute Myeloid Leukemia

Role of Circular RNA DLEU2 in Human Acute Myeloid Leukemia

Circ_KCNQ5 participates in the progression of childhood acute myeloid leukemia by enhancing the expression of RAB10 via binding to miR-622

Roles of hsa-miR-12462 and SLC9A1 in acute myeloid leukemia